Preparation of gold nanoparticles loaded MOF-199 for SERS detection of 5-hydroxyindole-3-acetic acid in serum

被引:6
|
作者
Zhou, Huimin
Zhu, Anni
Wang, Caiyin
Guo, Xiaoyu
Ying, Ye
Wu, Yiping
Liu, Xinling
Wang, Feng
Wen, Ying
Yang, Haifeng [1 ]
机构
[1] Shanghai Normal Univ, Key Lab Resource Chem, Educ Minist, Shanghai 200234, Peoples R China
基金
中国国家自然科学基金;
关键词
5-Hydroxyindole-3-acetic acid; SERS; MOF-199; Au nanoparticles; Biomarker; METAL-ORGANIC-FRAMEWORKS; ZEOLITIC IMIDAZOLATE FRAMEWORKS; URINARY-EXCRETION; FACILE SYNTHESIS; MOF; SEROTONIN; SORPTION; MARKER; ASSAY; SIZE;
D O I
10.1016/j.saa.2023.123280
中图分类号
O433 [光谱学];
学科分类号
0703 ; 070302 ;
摘要
5-Hydroxyindole-3-acetic acid (5-HIAA) is regarded as a biomarker for diagnosis of carcinoid tumors, and it is of great significance to developing a precision assay for monitoring 5-HIAA levels. In this work, gold nanoparticles loading on the surface of MOF-199 (Au NPs/MOF-199) is prepared to propose a surface enhanced Raman scattering (SERS) assay for 5-HIAA. When 4-mercaptopyridine (4-MPy) is used as a SERS probe, on Au NPs/MOF199, limit of detection (LOD) at 10-9 mol/L can be achieved. In addition, Au NPs/MOF-199 substrate with good preparation reproducibility shows long-term storage stability at 4 degrees C. Under optimal condition, the Au NPs/MOF199-based SERS method is applied to determine 5-HIAA in serum. The concentration linear range is from 10-9 to 10-5 mol/L and LOD is of 6.40 x 10-11 mol/L. Much importantly, Au NPs/MOF-199 substrate exhibits specific response toward 5-HIAA against other metabolites in the serum due to the capturing selectivity from porous MOF-199. The recoveries obtained on spiked human serum samples locate in the span from 94.30% to 106.00% with RSD of 4.01-7.43%. Au NPs/MOF-199-based SERS sensing strategy is a promising avenue for on-field monitoring biomedical species for clinic diagnosis purpose.
引用
收藏
页数:6
相关论文
共 50 条
  • [11] QUANTITATIVE ASPECTS OF URINARY INDOLE-3-ACETIC-ACID AND 5-HYDROXYINDOLE-3-ACETIC ACID EXCRETION
    HOSKINS, JA
    POLLITT, RJ
    JOURNAL OF CHROMATOGRAPHY, 1975, 109 (02): : 436 - 438
  • [12] CHROMATOGRAPHIC AND SPECTROMETRIC STUDIES ON CONVERSION PRODUCTS OF 5-HYDROXYINDOLE-3-ACETIC ACID
    FORNSTEDT, N
    JOURNAL OF CHROMATOGRAPHY, 1983, 270 (NOV): : 359 - 365
  • [13] ASSAY OF URINARY 5-HYDROXYINDOLE-3-ACETIC ACID - 2 METHODOLOGIES COMPARED
    BAARS, JD
    VANHAARD, PMM
    LOMBARTS, AJPF
    CLINICA CHIMICA ACTA, 1986, 158 (02) : 173 - 178
  • [14] ESTABLISHMENT OF ASSAYS FOR 5-HYDROXYINDOLE-3-ACETIC ACID (HIAA) - IDENTIFICATION OF INTERFERENCES
    CHRISTENSEN, SE
    CHEN, E
    CARLISLE, P
    MIYA, T
    WU, JT
    CLINICAL CHEMISTRY, 1990, 36 (06) : 1117 - 1117
  • [15] URINARY 5-HYDROXYINDOLE-3-ACETIC ACID (5-HIAA) BY LIQUID-CHROMATOGRAPHY
    KISER, EJ
    LONG, AR
    CLINICAL CHEMISTRY, 1983, 29 (06) : 1202 - 1202
  • [16] SPECIFIC ASSAY FOR URINARY 5-HYDROXYINDOLE-3-ACETIC ACID BY GAS-CHROMATOGRAPHY
    GOODWIN, BL
    RUTHVEN, CRJ
    WEG, MW
    SANDLER, M
    CLINICA CHIMICA ACTA, 1975, 62 (03) : 439 - 442
  • [17] EFFECT OF PHENYLALANINE METABOLITES ON URINARY EXCRETION OF INDOLE-3-ACETIC ACID AND 5-HYDROXYINDOLE-3-ACETIC ACID IN MAN
    TASHIAN, RE
    PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1960, 103 (02): : 407 - 410
  • [18] HOMOVANILLIC-ACID, VANILLYLMANDELIC ACID AND 5-HYDROXYINDOLE-3-ACETIC ACID ARE UNDETECTABLE IN URINE OF THE MUSKRAT
    YOSHIOKA, M
    YOSHIDA, A
    ICHIHASHI, Y
    SAITO, H
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1985, 33 (05) : 2145 - 2148
  • [19] High Plasma 5-Hydroxyindole-3-Acetic Acid Concentrations in Subjects With Metabolic Syndrome
    Fukui, Michiaki
    Tanaka, Muhei
    Toda, Hitoshi
    Asano, Mai
    Yamazaki, Masahiro
    Hasegawa, Goji
    Imai, Saeko
    Nakamura, Naoto
    DIABETES CARE, 2012, 35 (01) : 163 - 167
  • [20] QUANTITATIVE METHOD FOR DETERMINATION OF SEROTONIN AND 5-HYDROXYINDOLE-3-ACETIC ACID IN CEREBROSPINAL-FLUID
    KEMMERER, V
    KOCH, TR
    LICHTENFELD, KM
    CLINICAL CHEMISTRY, 1977, 23 (06) : 1122 - 1122